JD

Find the latest for JD company news

Opinion: DOGE is using AI the wrong way

President Trump and Elon Musk's DOGE initiative is misapplying artificial intelligence and missing its full potential.

Blockchain 4month
Docusign Stock Skyrockets 18% Amidst Record-Breaking AI Product Growth

In a remarkable turn of events, Docusign, the leading provider of digital transaction management solutions, has seen its stock price

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.

How pharmaceutical companies are training their workers on AI

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

ZJK Industrial: Growing, But NVDA Partnership Doesn't Promise Long Term Growth

Discover why (NASDAQ:ZJK) is rated as a HOLD. Explore its growth in EV, AI, Aerospace markets, strong finances, and challenges ahead.

AI hardware 5month
Feds drop bid to make Google sell AI investments — but still seek sale of Chrome

The DOJ and a coalition of 38 state attorneys general still seek a court order requiring Google to sell its Chrome browser and take other measures aimed at addressing what a judge said was Google's illegal search monopoly, according to court papers filed in Washington.

DOGE threat: How government data could give an AI company incredible power

DOGE access to government computers has sparked fears about cybersecurity vulnerabilities and privacy violations, as well as. the potential use of the data to train a private company's artificial intelligence system.

Cybersecurity 5month
Healthcare's AI dilemma: Faster diagnoses, but at what cost?

The use of LLMs in healthcare involves sensitive patient data, making privacy a critical concern. Data leakage, unauthorized information retention, and vulnerabilities to adversarial attacks pose significant risks to patient confidentiality.